Unilever PLC (UL)

Executive Summary / Key Takeaways

• The Ice Cream demerger completed in December 2025 created a structurally higher-margin business, boosting Unilever's ROIC by approximately 100 basis points to 19% and establishing a foundation for sustained margin expansion across four focused business groups.

• Unilever's pivot to volume-led growth is delivering tangible results, with underlying volume growth of 1.6% in 2025 and management committing to at least 2% multi-year volume growth, a rare achievement in mature consumer staples where pricing has historically driven performance.

• The company's aggressive portfolio rotation—15% of total turnover through acquisitions like Dr. Squatch and disposals of non-core assets—positions Unilever to capture premium segments and digital-native consumers, with the US market expected to reach 45% of turnover alongside India.

• A productivity program delivering €670 million in savings ahead of schedule, combined with an influencer-first marketing strategy shifting 50% of ad spend to social media, demonstrates management's focus on building a "marketing and sales machine" with world-class execution.

• Trading at $59.37 with a 19.7x P/E and 3.7% dividend yield, Unilever offers a compelling risk/reward profile, though investors must monitor material risks including €3.6 billion in Brazilian tax assessments and challenges attracting US talent in a competitive compensation environment.

Setting the Scene: From Diversified Conglomerate to Focused Growth Machine

Unilever PLC, founded in 1860 and incorporated in England and Wales in 1894, has spent the past five years dismantling a 165-year legacy of portfolio breadth to build something unprecedented in consumer staples: a focused, premium growth company that can deliver both volume expansion and margin improvement simultaneously. The November 2020 unification of Unilever N.V. into Unilever PLC was merely the structural prelude to a more profound transformation that accelerated in 2024-2025. During this period, management rotated 15% of the company's total portfolio through a series of strategic acquisitions and divestitures, culminating in the December 2025 demerger of the Ice Cream business into The Magnum Ice Cream Company N.V.

The significance lies in the fact that consumer staples have long been trapped in a zero-sum game: grow volume by sacrificing price, or expand margins by ceding market share. Unilever's strategic metamorphosis breaks this paradigm by jettisoning capital-intensive, low-margin businesses while doubling down on premium, digitally-native categories where brand equity translates to pricing power. The Ice Cream demerger alone distributed 80.15% of the business to shareholders while retaining a 19.85% stake, instantly improving the remaining group's gross margin profile and ROIC by roughly 100 basis points. This isn't financial engineering; it's surgical portfolio management that creates a structurally superior business.

The company now operates with four core business groups—Beauty & Wellbeing, Personal Care, Home Care, and Foods—each targeting higher-growth, higher-margin segments in the US and India, while expanding e-commerce footprint. This positioning directly addresses the industry's central challenge: traditional models of reach and persuasion have collapsed as consumer choice fragments across digital channels. CEO Fernando Fernandez, who took the helm in March 2025, has committed to making Unilever a "frontline company" with a "ruthless obsession with the consumer," focusing on driving demand and "desire at scale" in an increasingly digitized world. The shift suggests that Unilever is no longer a defensive dividend play but an offensive growth story built on premiumization and execution excellence.

Technology, Products, and Strategic Differentiation: Building a Marketing and Sales Machine

Unilever's competitive moat no longer rests solely on brand scale but on its ability to create and commercialize innovation platforms that generate €100-200 million in annual sales within 12-18 months. The 2025 launch of Persil Wonder Wash laundry liquid, which rolled out to over 30 markets and is positioned to become a €100 million platform, exemplifies this new model. Similarly, Hellmann's flavored mayonnaise range has scaled across more than 30 markets as a €100 million platform, while Vaseline's Gluta-Hya innovation drove the brand to 11% CAGR over four years with double-digit volume growth.

This capability is vital because it demonstrates Unilever has cracked the code on turning R&D into commercial velocity, a critical capability as product lifecycles compress and private label competitors erode traditional brand advantages. The company's innovation pipeline is no longer about incremental line extensions but breakthrough science combined with modern scaling techniques. Vaseline's success stems from three pillars: scientific superiority (Gluta-Hya technology), improved aesthetics (modern packaging and formulations), and content-at-scale distribution through influencers. This approach yields 10%+ volume growth in a category that historically grows 1-2% annually.

The strategic differentiation extends to demand generation. In March 2025, Fernandez unveiled an "influencer-first" strategy that aims to work with 20 times more influencers and shift 50% of advertising spend to social media, up from 30%. This isn't merely a channel shift; it's a fundamental reimagining of how brands build desire. The "4V model"—variety of creators, volume of content, virality, and velocity—creates a content flywheel that traditional TV advertising cannot match. Digital commerce now accounts for 17% of Unilever's revenue, with Amazon (AMZN) growing 15%, walmart.com (WMT) 25%, Flipkart India 30%, and TikTok globally at 70%. This digital acceleration provides real-time consumer feedback loops that shorten innovation cycles and improve ROI on marketing spend, directly supporting the 16.1% brand and marketing investment level—the highest in over a decade.

The acquisition strategy reinforces this premium focus. The 2025 purchases of Wild (natural deodorants) and Dr. Squatch (premium male grooming) enhance exposure to fast-growing, digitally-native segments where margins exceed traditional mass-market products. These aren't scale acquisitions; they're capability acquisitions that bring direct-to-consumer expertise and younger demographic reach. The result is a portfolio that commands higher price points, generates superior gross margins (46.95% in 2025), and is less vulnerable to retailer pricing pressure.

Financial Performance & Segment Dynamics: Evidence of Strategic Execution

Unilever's 2025 financial results serve as proof points for the strategic transformation, with underlying sales growth of 3.6% and underlying volume growth of 1.6% placing it in the top third of peers—a notable achievement in a slowing market environment. More importantly, the composition of growth validates the premiumization strategy. Beauty & Wellbeing delivered 4.3% USG with balanced volume (2.2%) and price (2.1%) contributions, while Personal Care achieved 4.7% USG with 1.1% volume and 3.6% price growth. This volume-led dynamic is precisely what management promised and what the market doubted.

The segment-level performance reveals where the value is being created. Beauty & Wellbeing's underlying operating margin of 19.2% (down 20bps) reflects increased brand investment behind Power Brands and premium innovations, a deliberate trade-off for long-term growth. Wellbeing brands—Liquid I.V., Nutrafol, OLLY—delivered double-digit growth, with Liquid I.V. becoming a billion-dollar brand and achieving record US household penetration of 18%. This is important because it demonstrates Unilever can build new platforms from scratch, reducing dependence on legacy brands. Prestige Beauty returned to growth in H2 2025, with Hourglass and K18 growing double-digit, indicating the premium acquisition strategy is working.

Personal Care's 22.6% underlying operating margin (up 50bps) shows the power of portfolio quality improvements. Dove, representing 40% of the business group, grew high single-digit through premium innovations in skin cleansing and deodorants. The whole body deodorant rollout across 15 markets reinforces category leadership while commanding higher price points. The Dr. Squatch acquisition expands Unilever's presence in the premium male grooming segment, which is growing 3x faster than mass market. This segment's margin expansion, driven by gross margin improvements and overhead efficiency, proves that premiumization and productivity can coexist.

Home Care's 2.6% USG (2.2% volume-led) and 14.9% margin (up 40bps) illustrate the turnaround story. After pricing missteps in Brazil that led to competitive share loss, management corrected course and restored growth. Wonder Wash's expansion to 30+ markets and Comfort's fragrance-led innovation drove share gains in Europe and India, where Home Care achieved its highest-ever market share. The implication is that even mature categories can deliver volume growth when innovation is combined with disciplined execution.

Foods delivered its highest-ever underlying operating margin of 22.6% (up 130bps) while growing 2.5% USG, proving that portfolio pruning and productivity gains can unlock hidden value. Hellmann's mid-single-digit volume growth and Knorr's retail strength offset foodservice weakness in China. The segment's margin expansion reflects disciplined pricing, mix management, and productivity—the exact formula Unilever is applying across the entire business.

The Ice Cream demerger's financial impact is substantial. The business generated €7.7 billion in 2025 revenue but lower margins and higher capital intensity. Its removal boosts the remaining group's ROIC to 19%, placing Unilever in the top third of the sector. The retained 19.85% stake, valued at €1.7 billion, provides capital flexibility while eliminating the drag of a low-margin, seasonal business. This is capital allocation that directly enhances shareholder returns.

Outlook, Management Guidance, and Execution Risk

Management's 2026 guidance frames the investment thesis in concrete terms: underlying sales growth at the bottom end of the 4-6% multi-year range, underlying volume growth of at least 2%, and a further modest improvement in underlying operating margin. This outlook signals confidence that the volume-led growth model is sustainable even in slower markets. CFO Srinivas Phatak's comment that "culturally and philosophically, we will keep overheads increases lower than sales" embeds productivity as a permanent habit, not a one-off program.

The margin expansion thesis rests on several pillars. Gross margin improvement in 2026 is expected to exceed 2025 levels, driven by mix improvement, procurement savings, enhanced commodity risk management, and capital investments directed toward savings. While inflationary pressures persist in select commodities (palm oil, canola oil, surfactants) and wage inflation continues, overall inflation is expected to be lower than 2025. Pricing is anticipated around 2%, a disciplined level that supports volume growth without eroding competitiveness.

The productivity program's acceleration provides execution confidence. Having delivered €670 million in savings by 2025, ahead of the €800 million target by 2026, management has freed resources for brand investment while expanding margins. This virtuous cycle—productivity funding growth, growth generating scale economies—is critical for sustaining both volume and margin expansion in a competitive environment.

However, execution risk remains. The guidance assumes continued outperformance in the US, where Unilever has delivered 12 consecutive quarters of volume growth. North America grew 5.3% in 2025 with 3.8% volume contribution, reflecting share gains and portfolio reshaping. But management acknowledges developed markets are softening, particularly in the second half of 2025. The ability to maintain 2%+ volume growth against this backdrop depends on flawless execution of the influencer-first strategy and innovation pipeline.

Emerging markets present a mixed picture. India remains a stronghold, with Home Care achieving record market share and the government GST reduction to 5% on 40% of the portfolio providing a 10% price reduction that should stimulate consumption. Indonesia is undergoing an operational turnaround after pricing missteps. China remains subdued, particularly in out-of-home consumption affecting Unilever Food Solutions. The guidance assumes these markets stabilize, but macroeconomic pressure across Latin America and retailer destocking in Brazil create downside risk.

Risks and Asymmetries: What Could Break the Thesis

The most material risk to Unilever's transformation is the €3.557 billion in indirect tax assessments in Brazil related to a 2001 corporate reorganization. This contingent liability, identified as a critical audit matter, represents potential cash outflows that could materially impact capital allocation. KPMG's audit commentary notes the complexity of local tax regimes and the possibility of further material assessments for unassessed periods. While Unilever has not recognized a provision, the risk of judicial deposits or guarantees if cases transition to Judicial Courts creates a tangible balance sheet threat. This could force Unilever to divert cash from growth investments or share buybacks to tax settlements, directly impairing the capital returns component of the investment thesis.

Talent retention poses a strategic vulnerability. The company acknowledges "significant gaps" in long-term incentive opportunity versus US peers, with only 7% of the next leadership level US-based. This reflects structural challenges attracting senior US talent into a UK compensation framework. In a market where US CPG competitors offer materially higher total compensation, Unilever risks losing the executional talent needed to deliver its "marketing and sales machine" vision. The proposed remuneration policy aims to reposition compensation at market median, but implementation risks and UK political sensitivity around executive pay could delay or dilute reforms.

The VMS (Vitamins, Minerals, and Supplements) category slowdown presents a growth risk. As a discretionary category, VMS is vulnerable to deteriorating US consumer confidence. While Liquid I.V. and Nutrafol delivered double-digit growth in 2025, peers are reporting category deceleration. If this trend accelerates, it could undermine the Wellbeing segment's contribution to overall growth and margin expansion, given these brands command premium pricing and high margins.

Competitive dynamics in core categories remain intense. In Latin American deodorants, Unilever's shift toward contact applicator formats at the expense of aerosols has reduced revenue per use and profit per use, contributing to market softness. Management is rebalancing investment toward aerosols, but this highlights how format innovation can cannibalize profitability if not carefully managed. In Brazilian laundry, Unilever's pricing actions took 8-12 weeks for competitors to match historically, but recent competitive responses were faster, forcing corrective pricing that weighed on margins. This demonstrates that even with strong brands, pricing power has limits when private label and local competitors are aggressive.

On the positive side, asymmetry exists in the digital transformation. If the influencer-first strategy and social commerce acceleration deliver disproportionate share gains among younger consumers, Unilever could exceed volume targets and expand margins faster than guidance suggests. The 70% year-over-year growth in TikTok commerce, while small in absolute terms, indicates channel momentum that competitors with traditional media models cannot easily replicate. Success here would validate the premium valuation and create a durable competitive advantage in demand generation.

Valuation Context: Pricing a Transforming Staple Giant

At $59.37 per share, Unilever trades at 19.7x trailing earnings and 12.5x EV/EBITDA, with a 3.7% dividend yield and 78.6% payout ratio. These multiples place Unilever in the middle of its peer group, but the valuation context must account for the strategic transformation. The 19% ROIC, boosted 100 basis points by the Ice Cream demerger, ranks in the top third of the sector and supports the company's AA2 credit rating target. This matters because it demonstrates that portfolio quality improvements are translating to superior capital returns, justifying a premium to slower-growth peers.

Comparing Unilever to direct competitors reveals both strengths and vulnerabilities. Procter & Gamble (PG) trades at 21.1x earnings with a 26.3% operating margin and 10.9% ROA, reflecting its premium focus and superior execution. Unilever's 20.0% operating margin and 8.4% ROA lag PG, but its 3.6% sales growth outpaced PG's 2% organic growth in 2025. Nestlé (NSRGY) trades at 21.5x earnings with a 14.9% operating margin, showing Unilever's margin expansion is competitive. Colgate-Palmolive (CL) commands a 32.1x earnings multiple with 60.1% gross margins, but its 1.4% organic growth significantly trails Unilever's volume-led approach.

The balance sheet provides strategic flexibility. With $3.9 billion in cash and $6.3 billion in free cash flow (TTM), Unilever can fund the remaining €130 million in productivity program costs, execute bolt-on acquisitions, and maintain its dividend while reducing net debt. The €1.5 billion share buyback completed in 2025 demonstrates commitment to capital returns, with a 70-30 balance between dividends and buybacks. Net debt/EBITDA of 1.61x is manageable and supports the AA2 credit rating ambition.

The portfolio transformation has improved earnings quality. The remaining business post-Ice Cream demerger has structurally higher gross margins and lower capital intensity. If management delivers on its 2026 guidance—2%+ volume growth, modest margin expansion, and continued productivity—the earnings multiple could compress while the business becomes more valuable. The key is execution consistency, which the 12-quarter US volume growth streak and ahead-of-schedule productivity program support.

Conclusion: The Convergence of Portfolio Quality and Execution Excellence

Unilever's investment thesis hinges on a simple but powerful convergence: a structurally superior portfolio is meeting world-class execution to deliver rare volume-led growth with margin expansion. The Ice Cream demerger wasn't just a disposal; it was a statement of intent to compete only where Unilever can win with premium brands and scale economies. The 2025 results provide evidence this strategy is working—1.6% underlying volume growth, 19% ROIC, and segment margins expanding through innovation and productivity.

The durability of the transformation is a key attraction. The productivity program is ahead of schedule and being embedded as a permanent habit. The influencer-first marketing strategy is shifting 50% of spend to social channels where Unilever can measure and optimize ROI in real-time. The US market, expected to reach 45% of turnover with India, is delivering 12 consecutive quarters of volume growth through premiumization and digital commerce. These are structural advantages built through deliberate strategic choices.

The critical variables to monitor are execution velocity in the US market, where competitive compensation gaps could slow talent acquisition, and the resolution of Brazilian tax contingencies, which could divert capital from growth investments. If Unilever can maintain its volume growth trajectory while expanding margins modestly, the current valuation offers attractive risk-adjusted returns for a business that has become more focused, more profitable, and more resilient. The transformation from diversified conglomerate to premium growth machine is not complete, but the 2025 results suggest it is irreversible.